Handelsman Y, et al.
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the management of dyslipidemia and prevention of cardiovascular disease algorithm – 2020 executive summary.
Endocr Pract 2020, 26: 1196-1224 (free full text).

Newman CB, et al.
Lipid management in patients with endocrine disorders: an Endocrine Society clinical practice guideline
J Clin Endocrinol Metab 2020, 105: dgaa674 (free full text).

Rosenzweig JL, et al.
Primary prevention of ASCVD and T2DM in patients at metabolic risk: an Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab 2019, 104: 3939–85 (free full text).

Arnett DK, et al.
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease.
J Am Coll Cardiol 2019, DOI: 10.1016/j.jacc.2019.03.010.

Jellinger PS, Handelsman Y, Rosenblit PD, et al.
American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of atherosclerosis.
Endocr Pract 2017, DOI:10.4158/EP171764.GL (free full text).

The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS).
2016 ESC/EAS guidelines for the management of dyslipidaemias.
Eur Heart J 2016, doi:10.1093/eurheartj/ehw272 (free full text).

Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members, Grundy SM, et al.
An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia—Full report.
J Clin Lipidol 2014, 8: 29-60.

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Circulation published online November 12, 2013. DOI: 10.1161/01.cir.0000437738.63853.7a (free full text).

Eckel RH, Jakicic JM, et al.
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Circulation published online November 12, 2013. DOI: 10.1161/01.cir.0000437740.48606.d1 (free full text).

Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, Stalenhoef AFH.
Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2012, 97: 2969–89.